Vimarsana
Biggest News Aggregation in the World

Page 4 - Imux News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Imux. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Imux Today - Breaking & Trending Today

Immunic, Inc. (NASDAQ:IMUX) Receives $22.00 Consensus PT from Analysts - Vimarsana News

Immunic, Inc. (NASDAQ:IMUX) Receives $22.00 Consensus PT from Analysts

Immunic, Inc. (NASDAQ:IMUX – Get Rating) has received a consensus rating of “Moderate Buy” from the six brokerages that are covering the firm, MarketBeat reports. One research analyst has rated the stock with a sell rating, one has issued a hold rating and four have issued a buy rating on the company. The average 1 […]

Source: wkrb13.com
Immunic, Inc. (NASDAQ:IMUX) Sees Significant Decrease in Short Interest - Vimarsana News

Immunic, Inc. (NASDAQ:IMUX) Sees Significant Decrease in Short Interest

Immunic, Inc. (NASDAQ:IMUX – Get Rating) was the recipient of a large decrease in short interest during the month of April. As of April 30th, there was short interest totalling 3,650,000 shares, a decrease of 14.7% from the April 15th total of 4,280,000 shares. Based on an average trading volume of 1,310,000 shares, the short-interest […]

Source: wkrb13.com
Immunic, Inc. (NASDAQ:IMUX) Short Interest Update - Vimarsana News

Immunic, Inc. (NASDAQ:IMUX) Short Interest Update

Immunic, Inc. (NASDAQ:IMUX – Get Rating) was the target of a significant decline in short interest in April. As of April 30th, there was short interest totalling 3,650,000 shares, a decline of 14.7% from the April 15th total of 4,280,000 shares. Based on an average trading volume of 1,310,000 shares, the days-to-cover ratio is presently […]

Head to Head Contrast: ObsEva (NASDAQ:OBSV) and Immunic (NASDAQ:IMUX) - Vimarsana News

Head to Head Contrast: ObsEva (NASDAQ:OBSV) and Immunic (NASDAQ:IMUX)

Immunic (NASDAQ:IMUX – Get Rating) and ObsEva (NASDAQ:OBSV – Get Rating) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, analyst recommendations, institutional ownership, earnings, risk, dividends and valuation. Institutional and Insider Ownership 60.7% of Immunic shares are held by […]

Immunic (IMUX) Set to Announce Quarterly Earnings on Thursday - Vimarsana News

Immunic (IMUX) Set to Announce Quarterly Earnings on Thursday

Immunic (NASDAQ:IMUX – Get Rating) is set to release its earnings data before the market opens on Thursday, May 11th. Analysts expect Immunic to post earnings of ($0.54) per share for the quarter. Immunic (NASDAQ:IMUX – Get Rating) last issued its earnings results on Thursday, February 23rd. The company reported ($1.63) earnings per share (EPS) […]